Mitesh Thakkar: BUY SBI Life, Lupin, Sun Pharma; SELL Equitas

Mitesh Thakkar: BUY SBI Life, Lupin, Sun Pharma; SELL Equitas

Market analyst Mitesh Thakkar has suggested three BUY Calls and one SELL call for today’s trading session. Indian markets are expected to open slightly positive on Friday. We have witnessed a choppy session yesterday due to F&O expiry but markets are now looking forward to next leg of the rally. The stocks are now positioned strong but we need the next trigger for stocks to move higher.

Pharmaceutical companies are on Thakkar’s radar for the trading session. He has suggested BUY Call for Lupin and Sun Pharma. Dr Reddy’s touched an all-time high in yesterday’s trading session. Traders can Buy Sun Pharma with a stop loss of Rs 499.50, target at Rs 533 as momentum in pharmaceutical counters could lead them to further gains. Traders can BUY Lupin with a stop loss of Rs 878, target at Rs 915.

Thakkar has suggested BUY Call for SBI Life. This stock is also on BUYING list of Prakash Gaba for today’s session. Traders can Buy SBI Life with a stop loss of Rs 899, target at Rs 944.

Thakkar has suggested SELL call for Equitas with a stop loss of Rs 52.5, target at Rs 47.

All trades should be carried out with strict Stop Loss. In case the trade doesn’t happen as per expectations, it is good to exit the trade if the call is in profit. TopNews will review performance of trading calls by the end of the trading session.

Business News: 
General: 
Analyst Views: 
Regions: